ClinicalTrials.Veeva

Menu

MicroRNA Correlates of Childhood Maltreatment and Suicidality

The University of Alabama at Birmingham logo

The University of Alabama at Birmingham

Status

Enrolling

Conditions

Major Depressive Disorder
Suicidal Ideation

Treatments

Other: Trier Social Stress Test

Study type

Observational

Funder types

Other
NIH

Identifiers

NCT04923685
IRB-300006024
5R01MH124248-02 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

This is a research study to find out if childhood trauma and stress are associated with depression or suicidal risk. The study will assess the effects of both short-term and long-term stress on biomarker (e.g. miRNA [MiRNA]) levels. miRNAs are a type of RNA (genetic material that is translated into protein) that are found in throughout the body and blood. They are called microRNA because their size is much smaller than typical RNA molecules. miRNAs are highly responsive to environment. This responsiveness is reflected in their expression in individuals who are affected by environment such as stress. The investigators are gathering genetic material, including DNA and RNA, from each participant. The RNA will be taken from the small vesicles and cells in the participant's blood and analyzed. The vesicles are small objects that occur normally in the blood and that contain RNA. This information may help us to understand the cause of mental illness and to improve medical and psychiatric care in the future. There will be 450 participants enrolled in this study.

Full description

The purpose of the study is to determine if the relationship between a history of childhood maltreatment (CM) and suicide risk is associated with alterations in the expression and epigenetic modification of specific microRNAs (miRNAs), thereby providing a molecular signature of suicide risk in people with CM. miRNAs are short regulatory RNAs that transduce environmental events into changes in protein synthesis in cells. The environment can induce permanent changes in miRNA expression. Aim 1 is to identify a set of neural-derived exosomal miRNAs that are associated with the interaction of suicidality and CM. Aim 2 is to examine whether an acute experimental stressor, the Trier Social Stress Test (TSST), impacts the expression of these miRNAs in suicidal patients with and without CM. Aim 3 will examine potential mechanisms by which altered miRNAs may contribute to CM-associated suicidal behavior. Aim 4 will examine if changes in CM-associated miRNAs are explained by modifications in their DNA methylation.

Enrollment

450 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Age 18-60
  2. Physically healthy
  3. Willing and able to provide informed consent

5. Diagnosis of MDD or No history of mental illness

Exclusion criteria

  1. Pregnancy or lactation (women of reproductive potential must have a negative urine pregnancy screen)
  2. Post-partum state (being within 2 months of delivery or miscarriage)
  3. Homicide risk as determined by clinical interview
  4. A lifetime history of psychotic disorder
  5. Any history of dissociation or dissociative disorder
  6. Bipolar disorder
  7. Pervasive developmental disorder
  8. Cognitive disorder
  9. Cluster A personality disorder
  10. Borderline personality disorder
  11. Anorexia nervosa
  12. Alcohol or drug dependence (except nicotine and caffeine) within the last month or the use of any hallucinogen (except cannabis), including phencyclidine in the last month (NOTE that a positive UDS is not exclusionary except for hallucinogens, methamphetamine, or cocaine. People presenting intoxicated with alcohol may be included when a Breathalyzer test (Alco-Sensor IV) is negative as long as there is no history of recent dependence.
  13. Recent myocardial infarction
  14. Unstable angina
  15. Active neoplasm in the past 6 months
  16. Immunosuppressive or corticosteroid therapy within the last month, with the following exceptions: any inhaled, intranasal, topical or vaginal corticosteroids are allowed.
  17. Chemotherapy
  18. Head injury with loss of consciousness in the past 6 months

Trial design

450 participants in 6 patient groups

MDD with elevated CM and suicidality scores
Description:
Major Depressive Disorder with elevator childhood maltreatment and suicidality scores.
Treatment:
Other: Trier Social Stress Test
MDD with CM history but lower suicidality
Description:
Major Depressive disorder with childhood maltreatment history but lower suicidality scores.
Treatment:
Other: Trier Social Stress Test
MDD without CM but with elevated suicidality
Description:
Major Depressive Disorder without childhood maltreatment, but with elevated suicidality scores.
Treatment:
Other: Trier Social Stress Test
MDD without CM but with lower suicidality
Description:
Major Depressive Disorder without childhood maltreatment but with lower suicidality scores.
Treatment:
Other: Trier Social Stress Test
Healthy controls with CM history
Description:
Healthy controls with childhood maltreatment history,
Treatment:
Other: Trier Social Stress Test
Healthy controls without CM history
Description:
Healthy controls without childhood maltreatment history.
Treatment:
Other: Trier Social Stress Test

Trial contacts and locations

2

Loading...

Central trial contact

Allison Stewart, BA; Richard C Shelton, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems